Brambilla E, Gazzeri S, Moro D, Caron de Fromentel C, Gouyer V, Jacrot M, Brambilla C
Service de Pathologie Cellulaire, Grenoble, France.
Am J Pathol. 1993 Jul;143(1):199-210.
Immunohistochemical analysis of p53 protein was carried out on 95 lung carcinomas from all histological types, including 60 primary tumors, 35 lymph node metastases, and 36 corresponding nude mice xenografts, using four antibodies: PAb240 specific for some mutant conformations; PAb421, PAb1801, and CM1 reactive with most of the forms of p53. Nuclear staining with at least two of those four antibodies revealed the presence of an accumulated protein, considered as indicative of a missense mutation in the p53 gene, in 50% of primary tumors of all histological types, except carcinoids. Some defect of messenger RNA expression was detected by Northern blot analysis in an additional 26% of tumors. p53 immunophenotype of the original tumor was fairly maintained on nude mice. p53 accumulation was not correlated with survival, but with disease extension (P = 0.01). Finally, immunohistochemical analysis allowed the recognition of p53 mutant immunophenotype in 41% of tumors where p53 DNA and messenger RNA were apparently normal, using standard molecular biology. Thus, this method provides a rapid and efficient approach for studying p53 mutations leading to an accumulated protein in lung tumors cells.
使用四种抗体对95例各种组织学类型的肺癌进行p53蛋白的免疫组织化学分析,这些肺癌包括60例原发性肿瘤、35例淋巴结转移瘤以及36例相应的裸鼠异种移植瘤。这四种抗体分别是:对某些突变构象具有特异性的PAb240;与大多数p53形式发生反应的PAb421、PAb1801和CM1。用这四种抗体中的至少两种进行核染色显示,除类癌外,所有组织学类型的原发性肿瘤中有50%存在蛋白积聚,这被认为是p53基因错义突变的指征。通过Northern印迹分析在另外26%的肿瘤中检测到一些信使RNA表达缺陷。原发肿瘤的p53免疫表型在裸鼠中得到了相当程度的保留。p53积聚与生存率无关,但与疾病进展相关(P = 0.01)。最后,使用标准分子生物学方法,免疫组织化学分析在41%的p53 DNA和信使RNA明显正常的肿瘤中识别出p53突变免疫表型。因此,该方法为研究导致肺肿瘤细胞中蛋白积聚的p53突变提供了一种快速有效的途径。